Our responsibility includes investing in research that could improve their care and giving vets accurate information about potential treatments. We're announcing two major investments today and we have a number of smaller announcements. First, HHS is committing up to 4.9 million through the Advanced Research Projects Agency for Health ARPA H to advance ibogaine treatment for PTSD. These awards will support scientific and regulatory manufacturing work necessary to prepare for future US Clinical trials. (09:18–09:33)
STATEMENT
Asserts that HHS is committing up to $4.9 million to advance ibogaine treatment for PTSD.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.